Penester, whose price is approximately 500 rubles.,
intended for the treatment of benign prostatic hyperplasia. The drug is a specific and
competitive inhibitor of the intracellular enzyme 5-alpha reductase (steroid), which converts testosterone to 5-dihydrotestosterone - an active androgen that promotes the growth of prostate tissue and the formation of benign hyperplasia. Under the influence of the medication, the severity of the symptoms of pathology is significantly reduced. Due to its effect, the concentration of dihydrotestosterone in both prostate tissue and plasma decreases. The active substance of the drug does not bind to androgen type receptors. The Penester drug does not affect the plasma content of lipids, cortisol, prolactin, estradiol, thyroxine,
thyroid-stimulating hormone.Indications
The Penester means of application recommends benign type prostate hyperplasia . The medication effectively reduces the size of the gland, increases the speed of the outflow of urine and reduces the manifestations of pathology. The drug prevents the risk of acute fluid retention in the urinary tract and the consequent likelihood of surgery.
Means "Penester". Instructions for use
The medicine is prescribed orally. The recommended dose is once a day for five milligrams. The drug is drunk regardless of the meal. The duration of treatment is at least six months. After six months, the effectiveness of therapy is assessed.
Medication "Penester". Instructions for use. Adverse reactions
The medicine provokes in some cases an increase in the content of follicle-stimulating and luteinizing hormones, testosterone. However, in the analysis, indicators remain within the normal range and increase by approximately 10% from the initial level. When taking the medicine, gynecomastia, a decrease in libido, tenderness in the mammary glands, a decrease in the amount of ejaculate, impotence are observed. As practice shows, the frequency of negative consequences is not more than 3-4%. During therapy, the severity of adverse reactions decreases.
Contraindications
The tool "Penester" instruction for use does not recommend for obstruction in the urinary tract, prostate cancer, in childhood. A medication is not prescribed for women, it is contraindicated in case of hypersensitivity.
additional information
Before the start of the therapeutic course, pathologies that can stimulate benign prostate hyperplasia should be excluded. Such diseases, in particular, include cancer of the gland, prostatitis (infectious), hypotension of the bladder, urethral stricture, as well as some changes in the urinary system that develop on the basis of certain diseases of the nervous system. Women during gestation, in reproductive age and during lactation should avoid contact with the drug with impaired integrity, especially with crushed tablets. The ability of a drug to inhibit the conversion of testosterone can adversely affect the development of male genital organs in the fetus.